SCHEMBL4077076

SCHEMBL4077076

C=C(C)C(=O)CC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL481170 0.81
SCHEMBL8469151 0.79 TSHR (0.37)
SCHEMBL23248545 0.79
SCHEMBL880629 0.79 TSHR (0.37)
SCHEMBL16424258 0.79 ALDH1A1 (0.48)
SCHEMBL108864 0.78 CA2 (0.61)
SCHEMBL8595701 0.78 SLC22A6 (0.41)
SCHEMBL25404425 0.77
SCHEMBL93309 0.77
SCHEMBL8817533 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230324801-A1 UNDERLAYER FILM FORMING COMPOSITION FOR LITHOGRAPHY, UNDERLAYER FILM, AND PATTERN FORMATION METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-10-12 US disclosed
US-11110175-B2 Compositions with permeation enhancers for drug delivery CHILDREN'S MEDICAL CENTER CORPORATION (US) 2021-09-07 US disclosed
CN-105801394-B The method that methacrolein is prepared by the tert-butyl alcohol 上海华谊新材料有限公司 2018-10-02 CN disclosed
US-20180153894-A1 FUSED BICYCLIC PYRIMIDINE DERIVATIVES AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-06-07 US disclosed
US-9980964-B2 ERK inhibitors and uses thereof CELGENE CAR LLC (BM) 2018-05-29 US disclosed
US-20180022713-A1 HETEROARYL COMPOUNDS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY 2018-01-25 US disclosed
US-9796700-B2 ERK inhibitors and uses thereof CELGENE CAR LLC (BM) 2017-10-24 US disclosed
US-20170267685-A1 HETEROARYL COMPOUNDS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY 2017-09-21 US disclosed
US-20170210729-A1 ERK INHIBITORS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY 2017-07-27 US disclosed
US-9695132-B2 Heteroaryl compounds and uses thereof CELGENE CAR LLC (BM) 2017-07-04 US disclosed
US-20160046634-A1 HETEROARYL COMPOUNDS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY 2016-02-18 US disclosed
US-20160002176-A1 ERK INHIBITORS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2016-01-07 US disclosed
US-9145387-B2 ERK inhibitors and uses thereof CELGENE AVILOMICS RESEARCH, INC. (US) 2015-09-29 US disclosed
US-20140296233-A1 HETEROARYL COMPOUNDS AND USES THEREOF SANOFI (FR) 2014-10-02 US disclosed
US-20140235782-A1 MACROMONOMER MIXTURE, TERMINAL-REACTIVE POLYMER MIXTURE, INTERMEDIATE FOR MACROMONOMER AND SILICONE HYDROGEL JOHNSON & JOHNSON VISION CARE, INC. (US) 2014-08-21 US disclosed
US-20140228322-A1 ERK INHIBITORS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2014-08-14 US disclosed
US-8748548-B2 Macromonomer mixture, terminal-reactive polymer mixture, intermediate for macromonomer and silicone hydrogel JOHNSON & JOHNSON VISION CARE, INC. (US) 2014-06-10 US disclosed
US-20110160385-A1 MACROMONOMER MIXTURE, TERMINAL-REACTIVE POLYMER MIXTURE, INTERMEDIATE FOR MACROMONOMER AND SILICONE HYDROGEL JOHNSON & JOHNSON VISION CARE, INC. 2011-06-30 US disclosed
JP-2009114414-A WATER ABSORBING RESIN PARTICLE, ABSORBER AND ABSORPTIVE ARTICLE SAN-DIA POLYMER LTD 2009-05-28 JP disclosed
US-20080187516-A1 ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2008-08-07 US disclosed